One of the researchers involved in Emory University's record-setting $525 million licensing deal for the HIV drug Emtriva plans to use part of his cut to set up a new bioscience company in Atlanta. Raymond Schinazi says he plans to spend about $12 million to start RFS Pharma, which will concentrate on developing antiviral and anti-cancer drugs. Another biotech company started by Schinazi, Pharmasset, recently announced plans to move to Princeton, New Jersey.
- read this report from the Atlanta Business Chronicle for more